SPRUCE BIOSCIENCES, INC. — Director's Dealing 2020

Oct 9, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SPRUCE BIOSCIENCES, INC. (SPRB)
CIK: 0001683553
Period of Report: 2020-10-08

Reporting Person: Dias Subaweerage (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2030-09-08	Common Stock (209035)		Direct

Footnotes

F1: All of the shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase. 19,003 of the shares subject to the stock option vest subject to satisfaction of time- and performance- based vesting conditions as follows: one-fourth of the shares vest on September 2, 2021, and the balance vests in equal monthly installments over the three years thereafter, provided that no shares vest unless and until we have achieved a specified clinical development milestone, and 190,032 shares of which vest over a four-year period commencing September 2, 2020, with 1/4th vesting on September 2, 2021 and 1/36th of the remaining shares vesting on a monthly basis thereafter.